Identification of Key Genes Associated with Overall Survival in Glioblastoma Multiforme Using TCGA RNA-Seq Expression Data
Open Access
Abstract
Background/Objectives: Glioblastoma multiforme (GBM) is an aggressive and heterogeneous brain tumor with poor prognosis, emphasizing the need for reliable molecular biomarkers to improve patient stratification and treatment planning. This study aimed to identify key genes associated with overall survival in GBM by employing and comparing machine learning (ML) and deep learning (DL) approaches using RNA-Seq gene expression data. Methods: RNA-Seq expression and clinical data for primary GBM tumors were obtained from The Cancer Genome Atlas (TCGA). A univariate Cox proportional hazards regression was used to identify survival-associated genes. For survival prediction, ML-based feature selection techniques—RF, GB, SVM-RFE, RF-RFE, and PCA—were used to construct multivariate Cox models. Separately, DeepSurv, a DL-based survival model, was trained using the significant genes from the univariate analysis. Gradient-based importance scoring was applied to determine key genes from the DeepSurv model. Results: Univariate analysis yielded 694 survival-associated genes. The best ML-based Cox model (RF-RFE with 90% training data) achieved a c-index of 0.725. In comparison, DeepSurv demonstrated superior performance with a c-index of 0.822. The top 10 genes were identified from the DeepSurv analysis, including CMTR1, GMPR, and PPY. Kaplan–Meier survival curves confirmed their prognostic significance, and network analysis highlighted their roles in processes such as purine metabolism, RNA processing, and neuroendocrine signaling. Conclusions: This study demonstrates the effectiveness of combining ML and DL models to identify prognostic gene expression biomarkers in GBM, with DeepSurv providing higher predictive accuracy. The findings offer valuable insights into GBM biology and highlight candidate biomarkers for further validation and therapeutic development.Keywords
This publication has 62 references indexed in Scilit:
- TSPYL1 as a Critical Regulator of TGFβ Signaling through Repression of TGFBR1 and TSPYL2Advanced Science, 2024
- Chronological horse herd optimization-based gene selection with deep learning towards survival prediction using PAN-Cancer gene-expression dataBiomedical Signal Processing and Control, 2023
- Phosphorylation of guanosine monophosphate reductase triggers a GTP-dependent switch from pro- to anti-oncogenic function of EPHA4Cell Chemical Biology, 2022
- Predicting breast cancer survivability based on machine learning and features selection algorithms: a comparative studyJournal of Ambient Intelligence and Humanized Computing, 2020
- Advances in the Knowledge of the Molecular Biology of Glioblastoma and Its Impact in Patient Diagnosis, Stratification, and TreatmentAdvanced Science, 2020
- An 11‐lncRNA expression could be potential prognostic biomarkers in head and neck squamous cell carcinomaJournal of Cellular Biochemistry, 2019
- RETRACTED: Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: A reviewBiomedicine & Pharmacotherapy, 2017
- Molecular and Genomic Alterations in Glioblastoma MultiformeThe American Journal of Pathology, 2015
- A Purine Nucleotide Biosynthesis Enzyme Guanosine Monophosphate Reductase Is a Suppressor of Melanoma InvasionCell Reports, 2013
- Overexpression of the long non‐coding RNA MEG3 impairs in vitro glioma cell proliferationJournal of Cellular Biochemistry, 2012